Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor CellsHsing-Chen Tsai, Cynthia A. Zahnow, Huili Li et al.|Cancer Cell|2012Cited by 652
Epigenetic therapy inhibits metastases by disrupting premetastatic nichesZhihao Lü, Malcolm V. Brock, Ray-Whay Chiu Yen et al.|Nature|2020Cited by 339
Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for CancerNidal Muvarak, Feyruz V. Rassool, Khadiza Chowdhury et al.|Cancer Cell|2016Cited by 211
Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and BrafV600E-Induced TumorigenesisYong Tao, Hariharan Easwaran, Byunghak Kang et al.|Cancer Cell|2019Cited by 191
Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic PropertiesXiangqian Kong, Stephen B. Baylin, Jie Chen et al.|Cancer Cell|2019Cited by 173